Released July 11, 2019 | SUGAR LAND
en
Europe's Pharmaceutical & Biotech Industry boasts 1,290 active capital and maintenance projects, all in various stages of planning, engineering and construction, representing $39 billion in potential investment value, according to Industrial Info's Project Database.
Of these projects, 810 have yet to begin construction and carry a total investment value of $12.5 billion. These projects range from annual maintenance programs to advanced manufacturing plants.Click here for a list of these projects, and see chart below for a breakdown by country.
Industrial Info offers the most comprehensive plant and project intelligence available for the global Pharmaceutical & Biotech Industry.
Of these projects, 810 have yet to begin construction and carry a total investment value of $12.5 billion. These projects range from annual maintenance programs to advanced manufacturing plants.Click here for a list of these projects, and see chart below for a breakdown by country.
Industrial Info offers the most comprehensive plant and project intelligence available for the global Pharmaceutical & Biotech Industry.
